Jill Rau is a Neurology physician affiliated with HonorHealth. OpenAlex indexes 19 publications with 704 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 85259
Telephone
480-301-8000Registry record last updated 1 Apr 2019.
Clinical trials
- Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
Sponsor: HonorHealth Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202538 payments$24,799openpaymentsdata.cms.gov ↗
- Lundbeck LLCProgram year20258 payments
- Averitas Pharma Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
93.6%Neuromuscular Blocker93.6%Onabotulinumtoxina100%Part B, office-administered≥40 patientsNervous system
5.6%Serotonin-1b and Serotonin-1d Receptor Agonist1.8%Rizatriptan33%Sumatriptan Succinate26%Naratriptan Hcl24%Eletriptan Hbr13%Zolmitriptan4%Part D<11 patientsCalcitonin Gene-related Peptide Receptor Antagonist1.3%Ubrelvy49%Qulipta29%Nurtec Odt22%Part D≥27 patients+ 8 more classes in this area
Metabolism & gastrointestinal
0.4%Serotonin-3 Receptor Antagonist0.4%Ondansetron Hcl62%Ondansetron Odt38%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Challenges in the management of idiopathic intracranial hypertension
Journal of NeuroInterventional Surgery
2026 - Clinical Features and Diagnosis of Spontaneous Intracranial Hypotension
CONTINUUM Lifelong Learning in Neurology
2025 - The contribution of lumbar puncture opening pressure in the diagnosis of spontaneous intracranial hypotension: A systematic literature review and meta‐analysis
Headache The Journal of Head and Face Pain
2025 - Clinical Features and Diagnosis of Spontaneous Intracranial Hypotension
CONTINUUM Lifelong Learning in Neurology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tania Phillips, MD
HonorHealth
Erkut Borazanci, MD, MS
HonorHealth
Zain Khalpey, MD, MRCS
HonorHealth
Venkatesh Ramaiah, MD
HonorHealth
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”